V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008572 | 240005233 | 1.85 | null | Palliative (P) | 2016-12-24 | 2017-01-13 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 02 | N | 240016513 | FLUOROURACIL + MITOMYCIN + RT |
| 240008573 | 240005233 | 1.69 | 73.3 | Not known (9) | 2016-04-24 | 2016-04-28 | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | 02 | N | 240016513 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008574 | 240005234 | 1.6 | null | Disease modification (D) | 2016-09-09 | 2016-09-10 | VEPEMB | 02 | null | 240016597 | CISPLATIN + ETOPOSIDE |
| 240008575 | 240005234 | 1.69 | 94.8 | null | null | 2015-10-03 | Cytarabine High Dose | null | null | 240016597 | CYTARABINE |
| 240008576 | 240005235 | 1.65 | 71 | Curative (C) | 2016-12-04 | 2016-12-08 | DOXORUBICIN | N | N | 240016607 | CISPLATIN + DOXORUBICIN |
| 240008577 | 240005236 | 1.7 | 72.5 | Curative (C) | 2014-02-03 | 2014-02-03 | CISPLATIN + FLUOROURACIL + RT | null | N | 240016663 | IPILIMUMAB |
| 240008578 | 240005237 | null | 76 | Curative (C) | 2015-07-19 | 2015-08-22 | Lomustine | N | N | 240016769 | BEAM |
| 240008579 | 240005237 | 1.83 | 79.6 | Palliative (P) | null | 2016-06-28 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 240016769 | CYTARABINE |
| 240008580 | 240005238 | null | 108.8 | Curative (C) | 2017-03-16 | 2017-03-19 | CAPECITABINE + OXALIPLATIN | N | N | 240016893 | BEVACIZUMAB |
| 240008581 | 240005239 | 1.65 | null | Not known (9) | 2018-04-17 | 2018-04-20 | BEVACIZUMAB + CISPLATIN + PACLITAXEL | 02 | null | 240016954 | CISPLATIN + ETOPOSIDE |
| 240008582 | 240005239 | null | 63 | Disease modification (D) | 2013-03-05 | 2013-03-08 | FCR Oral - Cycle 2 onwards | null | Y | 240016954 | CISPLATIN + FLUOROURACIL + RT |
| 240008583 | 240005240 | 1.48 | 86 | Curative (C) | 2014-03-15 | 2016-03-29 | R CODOX-M/ R IVAC | 01 | null | 240017029 | TRIPLE INTRATHECAL |
| 240008584 | 240005240 | 1.55 | 66.6 | Disease modification (D) | 2016-01-17 | 2016-01-21 | Cisplatin + Etoposide (3 day) | 02 | N | 240017029 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008585 | 240005241 | 1.64 | 0 | Palliative (P) | 2017-01-20 | 2017-01-20 | METHOTREXATE | 02 | N | 240017158 | CISPLATIN + ETOPOSIDE |
| 240008586 | 240005241 | 1.57 | null | null | 2017-12-18 | 2017-12-18 | Capecitabine | 2 | null | 240017158 | CAPECITABINE + OXALIPLATIN |
| 240008587 | 240005242 | null | 82 | Palliative (P) | 2017-02-15 | 2017-02-18 | CYCLOPHOSPHAMIDE + RITUXIMAB | Y | N | 240017222 | NORDIC |
| 240008588 | 240005243 | 1.55 | 59 | null | null | 2017-07-13 | Bevacizumab 15mg/kg | null | null | 240017250 | CVP |
| 240008589 | 240005243 | 1.71 | 75 | Curative (C) | 2017-01-30 | 2017-01-30 | CHOEP | N | N | 240017250 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 240008590 | 240005244 | 1.7 | 68 | Palliative (P) | 2017-09-13 | 2017-09-22 | GALLIUM TRIAL | 02 | N | 240017330 | CYTARABINE |
| 240008591 | 240005245 | 1.68 | 72.6 | null | 2014-03-27 | 2014-03-27 | Docetaxel + Gemcitabine with GCSF | N | null | 240017472 | FLAG |
| 240008592 | 240005245 | 1.68 | 68.5 | Curative (C) | null | 2016-05-19 | BEP 5 Day | N | null | 240017472 | CISPLATIN + VINORELBINE |
| 240008593 | 240005246 | null | 75.8 | Curative (C) | 2018-11-11 | 2018-11-11 | CYCLOPHOSPHAMIDE | 2 | null | 240017494 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008594 | 240005247 | 1.84 | null | Palliative (P) | 2016-09-08 | 2016-09-08 | DA-EPOCH-R | 02 | N | 240017540 | NORDIC |
| 240008595 | 240005248 | 1.55 | 144.9 | Disease modification (D) | 2016-06-23 | 2016-06-28 | CISPLATIN + FLUOROURACIL + RT | N | N | 240017598 | CHOEP |
| 240008596 | 240005249 | 1.6 | null | Neo-adjuvant (N) | 2018-06-30 | 2018-07-01 | Mitoxantrone | N | N | 240017609 | CARBO + FLUOROURACIL |
| 240008597 | 240005249 | 1.58 | 68.4 | Adjuvant (A) | 2015-11-19 | 2015-11-20 | FEC | N | N | 240017609 | BENDAMUSTINE + BORTEZOMIB |
| 240008598 | 240005250 | 1.52 | 77.7 | null | 2017-10-01 | 2017-10-03 | Bortezomib + Cyclophos + Dex | Y | N | 240017652 | PACLITAXEL + TRASTUZUMAB |
| 240008599 | 240005251 | 1.6 | null | Curative (C) | 2017-09-27 | 2017-10-26 | STS Rhabdomyosarcoma RMS 2005 IVA | null | N | 240017716 | TRASTUZUMAB |
| 240008600 | 240005252 | 1.8 | 74 | Curative (C) | 2016-01-10 | 2016-01-11 | CYCLOPHOSPHAMIDE + RITUXIMAB | 1 | N | 240017754 | ENZALUTAMIDE |
| 240008601 | 240005252 | 1.72 | 74.6 | Curative (C) | 2017-09-03 | 2017-09-09 | Carboplatin + Pemetrexed | N | N | 240017754 | AML17 TRIAL |
| 240008602 | 240005252 | null | 77.4 | 5 | 2018-01-15 | 2018-01-22 | UKALL 14 TRIAL | null | N | 240017754 | CAPECITABINE + RT |
| 240008603 | 240005253 | null | null | Disease modification (D) | 2015-06-25 | 2015-06-25 | Bortezomib + Cyclophos + Dex | N | null | 240017869 | VENETOCLAX |
| 240008604 | 240005253 | 1.79 | 103.6 | Palliative (P) | null | 2018-10-06 | VEPEMB | N | null | 240017869 | FCR |
| 240008605 | 240005254 | 1.54 | null | Palliative (P) | 2017-07-01 | 2017-07-10 | GemCarbo Days 1+8 | N | null | 240017924 | BEVACIZUMAB + CARBO + DOCETAXEL |
| 240008606 | 240005254 | 1.6 | 144.9 | Palliative (P) | 2018-09-05 | 2018-09-12 | CISPLATIN + FLUOROURACIL + RT | N | N | 240017924 | CAPECITABINE + OXALIPLATIN |
| 240008607 | 240005254 | 1.65 | 102 | Palliative (P) | 2014-07-11 | 2014-07-11 | IPILIMUMAB + NIVOLUMAB | N | N | 240017924 | BEVACIZUMAB |
| 240008608 | 240005255 | null | 76 | Disease modification (D) | 2016-05-18 | 2016-06-26 | TRASTUZUMAB | N | null | 240018081 | ETOPOSIDE |
| 240008609 | 240005255 | 1.77 | 63.2 | Palliative (P) | 2017-03-03 | 2017-03-06 | IBRUTINIB | 02 | N | 240018081 | IMATINIB |
| 240008610 | 240005256 | 1.64 | 105 | Disease modification (D) | 2016-09-24 | 2016-09-30 | Capecitabine | N | N | 240018120 | CARBOPLATIN + TOPOTECAN |
| 240008611 | 240005256 | 1.74 | 71.9 | Curative (C) | null | 2017-04-04 | ABVD | N | N | 240018120 | CISPLATIN + ETOPOSIDE |
| 240008612 | 240005257 | 1.71 | 82 | Curative (C) | 2017-07-18 | 2017-07-26 | Cytarabine HD + Methotrexate HD | 02 | N | 240018138 | FLAG + IDARUBICIN |
| 240008613 | 240005258 | 1.74 | 82.2 | Disease modification (D) | 2013-12-31 | 2014-01-04 | CYCLOPHOSPHAMIDE + THALIDOMIDE | N | N | 240018186 | R CODOX-M/ R IVAC |
| 240008614 | 240005259 | null | null | Palliative (P) | 2017-06-03 | 2017-06-05 | CYCLOPHOSPHAMIDE | 1 | null | 240018242 | CHOEP |
| 240008615 | 240005260 | 1.72 | 0 | Curative (C) | null | 2014-08-14 | DHAP - R | N | N | 240018318 | METHOTREXATE HIGH DOSE |
| 240008616 | 240010905 | 0 | 87 | Adjuvant (A) | null | 2017-09-21 | R-EPOCH | N | null | 240018328 | IVAC |
| 240008617 | 240005261 | 1.61 | 80 | Curative (C) | 2016-01-17 | 2016-01-28 | IMATINIB | N | N | 240018332 | CHOP R + METHOTREXATE |
| 240008618 | 240010906 | 1.61 | 53.3 | Curative (C) | 2016-12-29 | 2016-12-29 | Cisplatin + Vinorelbine (IV) | N | N | 240018369 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN |
| 240008619 | 240005262 | 1.45 | null | Curative (C) | 2014-10-27 | 2014-10-27 | Bortezomib | N | N | 240018409 | NILOTINIB |
| 240008620 | 240005263 | 1.78 | 73.3 | Curative (C) | 2017-09-12 | 2017-09-18 | CISPLATIN + GEMCITABINE | N | N | 240018437 | IBRUTINIB |
| 240008621 | 240005263 | null | 97.6 | Palliative (P) | null | 2017-06-02 | GALLIUM TRIAL | N | N | 240018437 | CARBOPLATIN + PEMETREXED |